Skip to content
Toggle navigation
About Us
Overview
Leadership Team
Board of Directors
Science & Platform
What is Immune Tolerance?
Our Approach
Pipeline
Overview
ACeD | Celiac Disease
MoveS-it | Multiple Sclerosis
Investors & Media
Overview
Press Releases
Publications
In the News
Careers
Contact
About Us
Overview
Leadership Team
Board of Directors
Science & Platform
What is Immune Tolerance?
Our Approach
Pipeline
Overview
ACeD | Celiac Disease
MoveS-it | Multiple Sclerosis
Investors & Media
Overview
Press Releases
Publications
In the News
Careers
Contact
Terms of Use
Privacy
Site Credits
Investors & Media
Press Releases
Press Releases
Press Releases
2023
2023
2022
2021
2020
2019
2018
2017
2015
2014
2012
May 09, 2023
Anokion Announces New Clinical Data from the Phase 1 ACeD Trial Supporting KAN-101 as a Potential Disease-modifying Treatment for Celiac Disease
Read More